RANTUM CAPITAL ACQUIRES LEADING MEDICAL TECHNOLOGY COMPANY TONTARRA

• Tontarra is a leading German developer and manufacturer of surgical instruments for open and minimally invasive surgery
• Attractive, structurally growing market with global demographic tailwinds, increasing demand for minimally invasive procedures, and high regulatory barriers to entry

The Rantum Private Equity Fund II has acquired TONTARRA Medizintechnik GmbH (“Tontarra”), headquartered in Wurmlingen. Tontarra is a leading German developer and manufacturer of high-precision, premium surgical instruments and endoscopy products for open and minimally invasive surgery. The company offers a comprehensive portfolio of precision instruments used across a broad range of surgical procedures. In addition to its proprietary branded business with patent-protected developments, Tontarra operates as a contract developer and manufacturer for internationally leading MedTech OEMs, covering the entire value chain from development and precision manufacturing through to regulatory approval.

Founded in 1966 by Reinhold Tontarra, the company is located in Wurmlingen within the medical technology cluster around Tuttlingen and operates a fully integrated production facility in Germany. With approximately 140 employees, more than 400 active customers worldwide, and comprehensive international certifications, Tontarra has established a strong and well-entrenched market position.

The previous managing partners, Thomas Tontarra and Alberto Petrella, have successfully led and significantly shaped the company over many years. Both will continue to support the company over the coming years as part of a structured transition phase. In addition to the current Managing Director, Fabienne Tontarra, the management team will be strengthened with Christoph Gerber as additional Managing Director. As a seasoned industry expert with extensive leadership experience in medical technology, he will drive the strategic development of the company in particular.

Thomas Tontarra comments: “We are delighted to have found in Rantum the right partner for the future. For us, it was essential to find a long-term oriented partner that supports Tontarra’s continued growth while understanding and valuing our corporate culture. This includes a clear commitment to the Wurmlingen site.”

“Tontarra is a company with an excellent position in a structurally attractive market – with fully integrated production, long-standing customer relationships, and a comprehensive certification base. We are excited to continue writing this growth story together with the outstanding management team. Through targeted investments in innovation as well as in the further development of products and markets, Tontarra will enter the next phase of its development and expand its leading market position,” adds Gilles Djordjevic of Rantum Capital.

The transaction is the seventh investment from the Rantum Private Equity Fund II, which focuses on majority stakes in mid-market companies in the DACH region.